Global Blood Therapeutics (GBT) Reports Q4 Loss of $0.74/Share
Tweet
Share
E-mail
Get Alerts GBT Hot Sheet
Join SI Premium – FREE
Global Blood Therapeutics (NASDAQ: GBT) reported Q4 EPS of ($0.74), versus ($0.53) reported last year.
For earnings history and earnings-related data on Global Blood Therapeutics (GBT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- QT Imaging reports 116% revenue jump in first half of 2026
- HawkEye 360 wins NRO contract for commercial RF data services
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
